Cedars Sinai Medical Center appeared to be the Corporate Investor, which was created in 1902. The company was established in North America in United States. The main department of described Corporate Investor is located in the Los Angeles.
The fund is constantly included in less than 2 deals per year. Opposing the other organizations, this Cedars Sinai Medical Center works on 0 percentage points less the average amount of lead investments. The important activity for fund was in 2019. The common things for fund are deals in the range of 5 - 10 millions dollars. Considering the real fund results, this Corporate Investor is 9 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2015.
The fund was created by Kaspare Cohn.
Among the most popular portfolio startups of the fund, we may highlight Capricor Therapeutics, Emulate, Health Care DataWorks. Among the most successful fund investment fields, there are Biotechnology, Wellness. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Cedars Sinai Medical Center, startups are often financed by The Cedars-Sinai Accelerator, Techstars, Techammer. The meaningful sponsors for the fund in investment in the same round are NanoDimension, Vertical Venture Partners, Techstars. In the next rounds fund is usually obtained by Techammer, OS Fund, National Institutes of Health.
|AMI Opportunities Fund||Israel, Tel Aviv, Tel Aviv District|
|Arnerich Massena & Associates||Oregon, Portland, United States|
|Climb Ventures||Geneva, Geneve, Switzerland|
|Evergreen Pacific Partners||Seattle, United States, Washington|
|fullVenture||Community of Madrid, Madrid, Spain|
|Ground Up Ventures||New York, New York, United States|
|Harlan Capital Partners LLC||New York, New York, United States|
|HealthInvest Equity Partners||Connecticut, Stamford, United States|
|Heaven-Sent Capital Management||Beijing, Beijing, China|
|LINICO Corporation||Carson City, Nevada, United States|
|MEIF Proof-of-Concept & Early Stage Fund||-|
|Natixis Private Equity||France, Ile-de-France, Paris|
|Omega Media||Norway, Oslo|
|SFJ Pharmaceuticals||California, Pleasanton, United States|
|SIEGMUND Investment Company||Germany, Thuringen, Thuringia|
|Teleios Investment Group||Flat Rock, North Carolina, United States|
|Trinity Capital Investment||Arizona, Phoenix, United States|
|U.S. Environmental Protection Agency||District of Columbia, United States, Washington|
|Velt Partners||Andalucia, Andalusia, Spain|
|$35M||29 Jun 2022||San Jose, California, United States|
|$19M||22 Jun 2022||Raleigh, North Carolina, United States|
|$100M||01 Mar 2022||San Jose, California, United States|
|$10M||29 Jun 2021||London, England, United Kingdom|
|$130M||09 Nov 2020||San Diego, California, United States|
|$70M||04 May 2020||San Jose, California, United States|
|$1M||19 Dec 2019||Minneapolis, Minnesota, United States|
|$7M||22 Apr 2019||Boston, Massachusetts, United States|
|$6M||05 Mar 2019||Seattle, Washington, United States|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.